F2RL1 and head and neck squamous cell carcinoma: A nomogram was constructed to estimate 1-, 3- and 5-year OS.<h4>Conclusion</h4>F2RL1 is reproducibly overexpressed in HNSCC and is linked to adverse outcomes and immune-related features, supporting its potential as a prognostic biomarker and candidate therapeutic target.